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Sequence-specific pyrrole-imidazole polyamides can
be designed to interfere with transcription factor bind-
ing and to regulate gene expression, both in vitro and in
living cells. Polyamides bound adjacent to the recogni-
tion sites for TBP, Ets-1, and LEF-1 in the human immu-
nodeficiency virus, type 1 (HIV-1), long terminal repeat
inhibited transcription in cell-free assays and viral rep-
lication in human peripheral blood lymphocytes. The
DNA binding activity of the transcription factor Ets-1 is
specifically inhibited by a polyamide bound in the minor
groove. Ets-1 is a member of the winged-helix-turn-helix
family of transcription factors and binds DNA through a
recognition helix bound in the major groove with addi-
tional phosphate contacts on either side of this major
groove interaction. The inhibitory polyamide possibly
interferes with phosphate contacts made by Ets-1, by
occupying the adjacent minor groove. Full-length Ets-1
binds the HIV-1 enhancer through cooperative interac-
tions with the p50 subunit of NF-kB, and the Ets-inhib-
itory polyamide also blocks formation of ternary Ets-
1zNF-kBzDNA complexes on the HIV-1 enhancer. A
polyamide bound adjacent to the recognition site for
NF-kB also inhibits NF-kB binding and ternary complex
formation. These results broaden the application range
of minor groove-binding polyamides and demonstrate
that these DNA ligands are powerful inhibitors of DNA-
binding proteins that predominantly use major groove
contacts and of cooperative protein-DNA ternary
complexes.
Pyrrole-imidazole polyamides are a novel class of small mol-
ecules that bind predetermined DNA sequences in the minor
groove. Sequence-specific DNA recognition depends on side-by-
side pairing of pyrrole (Py)1 and imidazole (Im) amino acids; a
Py opposite an Im targets a CzG base pair, and an Im opposite
a Py targets a GzC base pair (1, 2). Py/Py, Py/b-alanine (b), and
b/b pairs binds both AzT and TzA base pairs (2, 3). Recent
studies have shown that A/T degeneracy can be overcome by
replacing one pyrrole ring of the Py/Py combination with 3-hy-
droxypyrrole (Hp), with the result that the Hp/Py prefers TzA
over AzT base pairs (4). In addition to their high specificity,
polyamides bind DNA with affinities comparable to or even
higher than those of natural DNA-binding transcription fac-
tors. Polyamides can be designed to interfere with specific
DNA-binding proteins and as a result inhibit their function. We
have shown that DNA binding of transcription factor TFIIIA
was inhibited by a polyamide that bound within the recognition
site of zinc finger four of this nine-finger protein. TFIIIA is an
important regulator of transcription of 5 S RNA genes, and as
a result, transcription of 5 S RNA genes was suppressed in
vitro as well as in cultured Xenopus cells with this specific
polyamide (5). Mismatch polyamides, differing from the match
polyamide in either the sequence of Py and Im rings or a single
atom substitution, were without effect on either TFIIIA bind-
ing or transcription.
In an attempt to extend the application range of these small
molecules to messenger RNA/protein-coding genes, and to a
medically relevant system, specific polyamides were designed
to interfere with transcription of the human immunodeficiency
virus type 1 (HIV-1) (6). Transcription of HIV-1 is regulated by
the 59 long terminal repeat (LTR), which contains a series of
cis-acting sequences responsible for basal and inducible viral
gene expression. These sequences are well characterized and
include recognition sites for upstream stimulatory factor, the
E-twenty six-specific (ets) family of proteins, lymphoid enhanc-
er-binding factor-1 (LEF-1), the nuclear factors NF-kB, Sp1,
and the TATA box-binding protein (TBP) (reviewed in Ref. 7).
TBP is indispensable for initiation of transcription, and LEF-1,
considered to be an architectural protein, plays a central role in
coordinating activities of multiple transcription factors. LEF-1
was shown to bend DNA, which facilitates protein-protein in-
teractions between transcription factors bound at distant sites
in enhancers (8–12). A polyamide was designed to bind a
7-base pair sequence located on each side of the TATA box and
immediately upstream of the Ets-1 recognition site in the
HIV-1 promoter (designated polyamide 1, see Fig. 1). This
polyamide prevented TBP and Ets-1 from binding to their
recognition sites and blocked basal transcription from the
HIV-1 promoter, but not from an unrelated promoter, in vitro.
A second polyamide (designated polyamide 3, Fig. 1), which
was targeted to a sequence immediately upstream from the
LEF-1-binding site and immediately downstream from the Ets-
1-binding site, prevented LEF-1 from binding and blocked ac-
tivated transcription in vitro. Polyamide 3, however, did not
inhibit Ets-1 DNA binding. Mismatch polyamides 2 and 4 had
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no effect on the DNA binding activity of TBP, LEF-1, or Ets-1.
A combination of the two polyamides together effectively
blocked viral transcription and replication in cultured human
peripheral blood lymphocytes (6). The transcriptional activity
of a variety of major T-cell-specific cellular genes (cytokine and
growth factor genes) was also examined, and the expression of
none of these genes was affected by the polyamides. Hence, it
was concluded that inhibition of viral replication was the result
of direct interference of the polyamides with transcription fac-
tor binding on the HIV-1 enhancer/promoter.
In the present study, we have focused on the differential
inhibition of Ets-1 DNA binding by two distinct Py-Im poly-
amides and on the cooperative interaction between Ets-1 and
the p50 subunit of NF-kB, which is necessary for HIV-1 en-
hancer function (13). The ets proteins are attractive candidates
for polyamide targeting because of their unique mode of bind-
ing to DNA; the recognition helix of the winged helix-turn-helix
domain is embedded in the major groove at the center of the
DNA-binding site, and loop regions flanking the recognition
helix are anchored to the phosphate backbone on both sides of
the DNA recognition site (14–16). So far, we have demon-
strated polyamide inhibition of DNA binding domains that
exclusively contact the minor groove of DNA, such as zinc
finger four of TFIIIA (5), the high mobility group domain of
LEF-1, and the “saddle” of TBP (6). Recently, it was shown that
a polyamide containing a basic tripeptide tail could inhibit the
DNA binding activity of the basic helix-leucine zipper protein
GCN4 that contacts DNA exclusively in the major groove (17).
Since many transcriptional regulators contact DNA in the ma-
jor groove with additional contacts in the minor groove and
with the phosphate backbone, it is of interest to know the
mechanism by which polyamides can inhibit a member of this
class of proteins.
Ets-1, like most other ets proteins, functions in association
with other proteins. Complex formation between ets proteins
and other factors can release the autoinhibitory effects on DNA
binding of full-length Ets proteins (reviewed in Refs. 18 and
19). It was shown that Ets-1 physically and functionally inter-
acts with AP-1 in normal and activated T-cells (20). Ets-1 does
not bind the minimal T-cell receptor a-gene by itself, but it
binds DNA cooperatively with a factor called CBFa2 (11). Re-
cently, Ets-1 was identified as a factor that physically associ-
ates with the POU homeodomain protein GHF-1/Pit-1 to fully
reconstitute prolactin promoter activity (21). The p50 subunit
of NF-kB was shown to associate with Elf-1, and this associa-
tion plays a role in regulating cell type-specific and inducible
expression of the interleukin 2 receptor a-chain gene (22).
Significantly, physical interactions between ets and NF-kB/
NFAT proteins were shown to play an important role in their
cooperative activation of the HIV-1 enhancer in T-cells (13). We
show here that full-length Ets-1 and the p50 subunit of NF-kB
bind DNA cooperatively and form a ternary complex on the
HIV-1 enhancer. This cooperative binding is also effectively
inhibited by polyamide 1, which may be an important contrib-
uting factor to the highly effective shut down of the HIV-1
promoter observed in vivo (6). Taken together, these findings
demonstrate that the application range of the small Py-Im
polyamides may be broader than anticipated. Polyamides can
inhibit DNA-binding domains that make both major and minor
groove DNA contacts, provided that the polyamide interferes
with the minor groove binding portion, and polyamides can
inhibit protein-protein-DNA ternary complexes, which may be
an important consideration in designing future therapeutic
drugs.
EXPERIMENTAL PROCEDURES
Polyamides—Polyamides were synthesized by solid phase methods
as described previously (23).
Ets-1 Protein Purification—Recombinant full-length Ets-1 and the
DN331 deletion polypeptide were expressed in bacteria and purified as
described previously (24, 25). The high affinity deletion construct,
DN331, contains the Ets-1 DNA-binding domain without the auto-
inhibitory regions and binds DNA with a 23-fold higher affinity than
native, full-length Ets-1 (25). Purified proteins were stored in 20 mM
sodium citrate, pH 5.3, 1 mM EDTA, 500 mM KCl at 4 °C.
Gel Mobility Shift Assays—Three sets of complementary oligonucleo-
tides were synthesized (Genosys Biotechnologies, Inc.) for use as dou-
ble-stranded probes in gel mobility shift experiments. A 43-bp oligonu-
cleotide corresponded to positions 2160 to 2117 of the HIV-1 enhancer
and contained the binding sites for Ets-1, LEF-1, and polyamides 1 and
3 in their natural sequence context. A 38-mer corresponded to positions
2160 to 2144 of the HIV-1 enhancer, followed immediately by an
NF-kB-binding site (Fig. 4A). This artificial probe contained the binding
sites for polyamide 1 and 3 and Ets-1 in their natural sequence context,
followed by the first NF-kB recognition site located at position 2104 to
292 of the HIV-1 enhancer. A 73-mer oligonucleotide corresponded to
positions 2160 to 292 of the HIV-1 enhancer and contained the binding
sites for polyamides 1 and 3, Ets-1, LEF-1, and NF-kB in their natural
sequence context plus four additional bases at the 39 end. Equimolar
amounts of two complementary oligonucleotides were combined and
end-labeled with [g-32P]ATP and T4 polynucleotide kinase. After label-
ing, unincorporated nucleotides were removed using a Qiaquick nucle-
otide removal kit (Qiagen). The labeled oligonucleotides were annealed
and used in gel mobility shift experiments at a final concentration of 1
fmol/20 ml (50 pM). A 143-bp polymerase chain reaction (PCR) product,
corresponding to nucleotide positions 2175 to 233 of the HIV-1 LTR,
was also used in gel mobility shift experiments. Binding reactions were
carried out in a 20-ml reaction volume with 25 mM Tris/HCl, pH 7.9, 6
mM MgCl2, 65 mM KCl, 10 mM dithiothreitol, 0.5 mM EDTA, 10% (v/v)
glycerol, and 100 mg/ml bovine serum albumin. The reactions also
contained 0.5 mg of poly(dI)zpoly(dC) as a nonspecific competitor. Ets-1,
DN331, and NF-kB p50 (Promega Corp.) were diluted in binding buffer
immediately before adding to the samples, which were then incubated
on ice or at ambient temperature for 20 min. The bound and free DNA
were resolved on a 6% non-denaturing polyacrylamide gel containing 44
mM Tris borate, pH 8.3, and 1 mM EDTA. The gels were dried and
exposed to Kodak Biomax film. The results were quantitated using an
LKB Laser densitometer or with a Molecular Dynamics PhosphorIm-
ager equipped with ImageQuant software.
DNase I Footprint Experiments—The probe used in DNase I footprint
experiments was a 250-bp EcoRV/BglII restriction fragment from the
plasmid pHIV LTR-CAT (obtained from Dr. K. A. Jones) (26), which was
singly end-labeled at the 39 end of the BglII site with the Klenow
fragment of DNA polymerase. Thus, the top strand was labeled. DNase
I digestions were carried out in a 50-ml reaction containing 50 pM
labeled DNA and 1 mg of poly(dI)zpoly(dC) in the same binding buffer
that was used for gel mobility shift experiments. The DNA was incu-
bated with polyamides for 20 min at ambient temperature, followed by
addition of DN331, and incubation for 20 min on ice. DNase I digestion
was allowed to proceed in the presence of 2.5 mM CaCl2 and 5 mM MgCl2
for 30 s at ambient temperature with 66 3 1023 or 33 3 1023 units of
DNase I (Roche Molecular Biochemicals) in the samples with or without
protein, respectively. Reactions were stopped by the addition of 0.2%
SDS and 10 mM EDTA, extracted with phenol/chloroform, and precipi-
tated with ethanol prior to electrophoresis on a 6% denaturing poly-
acrylamide gel containing 8.3 M urea, 88 mM Tris borate, pH 8.3, and 2
mM EDTA. The dried gels were exposed to Kodak Biomax film with
DuPont Cronex Lightning Plus intensifying screens at 280 °C.
RESULTS
Polyamide-binding sites within the HIV Enhancer—A set of
four Py-Im polyamides 1-4 (Fig. 1) was synthesized by solid
phase methods, and their structures have been published (6).
Binding affinities for each polyamide were previously deter-
mined by quantitative DNase I footprinting experiments (6).
Polyamide 1 (ImPy-b-ImPy-g-ImPy-b-ImPy-b-Dp; where b is
b-alanine, g is g-aminobutyric acid, and Dp is dimethylamin-
opropylamide) binds the sequence 59-AGCTGCA-39 with an
equilibrium dissociation constant (Kd) of 0.05 nM, whereas the
mismatch polyamide 2 (ImIm-b-ImIm-g-PyPy-b-PyPy-b-Dp)
exhibits 100-fold lower affinity for binding that site. Polyamide
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3 (ImPyPyPy-g-ImPyPyPy-b-Dp) binds the sequence 59-AG-
TACT-39 with a Kd of 0.06 nM, and the mismatch polyamide 4
(ImPyPyPy-g-PyPyPyPy-b-Dp) binds the same sequence with a
33-fold lower affinity.
Polyamide 1-binding sites are found in the HIV-1 promoter
and enhancer immediately flanking the TATA element and
partially overlapping the upstream side of the Ets-1-binding
site, at nucleotide positions 2153 to 2147 (relative to the start
site for transcription at 11) (Fig. 1). The consensus recognition
site for Ets-1 is located at nucleotide positions 2149 to 2141
(Fig. 1). DNase I footprinting revealed additional binding sites
for polyamide 1 located within adjacent vector DNA sequences
(see Fig. 2C). Polyamide 3 binds to a site at nucleotide positions
2141 to 2136 within the HIV-1 enhancer, adjacent to the
recognition sequence for LEF-1 (2135 to 2126), and partially
overlapping the downstream side of the Ets-1 recognition site
(Fig. 1). Additional recognition sites for polyamide 3 are found
in the HIV-1 promoter/enhancer and coding sequence (see Ref.
6 and Fig. 2C). Therefore, both polyamides have the potential
to block DNA binding by Ets-1 in addition to LEF-1 and TBP.
Differential Inhibition of Ets-1 DNA Binding by Polyamides
1 and 3—We previously reported that the DNA binding activity
of the isolated high affinity DNA binding domain of Ets-1 was
specifically inhibited by polyamide 1 but not by polyamide 3 (6).
We wished to explore the basis for this differential inhibition in
detail. A set of two complementary oligonucleotides corre-
sponding to position 2160 to 2117 was synthesized and end-
labeled followed by annealing of both strands. This 43-bp probe
contained the binding sites for polyamide 1, Ets-1, polyamide 3,
and LEF-1. Gel mobility shift experiments were done with a
deletion peptide DN331, which contains the DNA-binding do-
main but lacks the autoinhibitory regions present in the full-
length protein, and as a result binds DNA with substantially
higher affinity than full-length Ets-1 (24, 25). The reported Kd
for DN331 binding to a synthetic Ets site, termed SC1, is 8.5
pM, a 23-fold higher affinity than that observed for the full-
length protein binding the same DNA probe (25). When DN331
(at a concentration of 12 nM) was added to the labeled, 43-bp
HIV-1 oligonucleotide (at a concentration of 50 pM), approxi-
mately 80% of the probe was converted into a protein-DNA
complex (Fig. 2A, lane 2). In separate protein titration experi-
ments with both the SC1 and HIV-1 probes, we found that
DN331 had an ;10-fold lower affinity for the HIV-1 probe
compared with the SC1 probe (data not shown). This difference
in binding affinity is likely due to the different sequences of the
Ets-1 sites within these two probes rather than to the length of
the two DNA probes (23 bp for the SC1 probe versus 43 bp for
the HIV-1 probe and three nucleotide differences within the
respective 9-bp Ets-1 sites (25)). When polyamides were prein-
cubated with the DNA probe before adding DN331, polyamide
1 prevented Ets-1zDNA complex formation (Fig. 2A, lanes
3–10). In contrast, polyamide 3 had no effect on Ets-1 DNA
binding, even at a concentration as high as 200 nM (Fig. 2B and
Ref. 6). When both polyamides were combined, the degree of
inhibition was very similar to that observed with polyamide 1
alone (data not shown). Quantitation of these gel mobility shift
experiments revealed that polyamide 1 inhibited Ets-1
DN331zDNA complex formation by 50% at a concentration of
approximately 6 nM, and nearly complete inhibition was
achieved between 50 and 200 nM polyamide (Fig. 2B). Polyam-
ide 3, and the two mismatch polyamides 2 and 4, had virtually
no effect on DN331 DNA binding in the same concentration
range (Fig. 2B and Ref. 6).
Polyamide 1 Prevents Ets-1 DNA Binding, Whereas Polyam-
ide 3 Coexists with Ets-1 on Overlapping DNA-binding
Sites—We employed DNase I footprinting to visualize the DNA
sequence contacts made by polyamides 1 and 3 and by DN331.
A labeled DNA fragment derived from the HIV-1 enhancer was
incubated with each polyamide either alone or followed by
addition of DN331 and a further 30-min incubation. As ex-
pected, both polyamides bound their target sites within the
HIV-1 enhancer with high affinity (Fig. 2C, lanes 3–5 and
11–13). Additional sites for polyamide 1 are present in up-
stream vector DNA sequence (lane 5), and additional sites for
polyamide 3 are located both in the vector and in the HIV-1
enhancer sequence (lane 13 and see Ref. 6). The Ets-1 footprint
is characterized by two DNase I-hypersensitive sites appearing
in the center and at the 59 boundary of the footprint (lanes 6
and 14). These hypersensitive sites disappear with the addition
of 20–100 nM polyamide 1 (Fig. 2C, lanes 7–9) but remain
unchanged with the addition of polyamide 3 (lanes 15–17). The
simultaneous presence of polyamide 3 and DN331 results in a
broadening of the footprint, corresponding to a combined foot-
print created by DN331 and polyamide 3 (lanes 15–17),
whereas the Ets-1 footprint is replaced by the polyamide 1
footprint (lanes 7–9).
Order of Addition Determines the Inhibitory Activity of Pol-
yamide 1—An order of addition experiment was performed to
determine whether polyamide 1 could disrupt a preformed
Ets-1zDNA complex (Fig. 3). Various concentrations of polyam-
ide 1 were added to the DNA probe, in separate reactions,
either 20 min before DN331, simultaneously with DN331, or
after incubation of the probe with DN331 for 30 min. After an
additional 20 min incubation, the reactions were subjected to
nondenaturing gel electrophoresis, and the fraction of DNA in
the Ets-1zDNA complex was determined by phosphorimage
FIG. 1. Polyamide and transcription factor-binding sites in the
HIV-1 promoter/enhancer. Top, DNA-binding sites for transcription
factors and polyamides 1 and 3 (indicated by numbers above vertical
arrows) in the HIV-1 promoter/enhancer. Nucleotide positions are
shown relative to the major start site for transcription (11). Middle, the
double-stranded DNA sequence encompassing the Ets-1 and LEF-1
recognition sites and flanking sequences is shown. Polyamides are
represented schematically between the two DNA strands at their re-
spective binding sites. The closed and open circles represent Im and Py
rings, respectively; the diamonds represent b-alanine (b), and the
curved lines represent g-aminobutyric acid (g). The Ets-1- and LEF-1-
binding sites are boxed. DNA binding by Ets-1 involves two types of
sequence-specific DNA recognition; in the center of the site, amino acids
within the recognition helix directly contact the 59-GGA(A/T)-39 core in
the major groove, whereas backbone phosphates are contacted on the
two flanks (closed squares) (15, 16, 30, 31, 37). The selected consensus
for an optimal Ets-1-binding site is indicated below the duplex sequence
(35). The bases of the Ets-1-binding site are numbered, starting with 1
for the first G of the GGA core (16). Bottom, binding models for mis-
match polyamides 2 and 4, where the mismatches are boxed.
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analysis. Fig. 3 shows the results of these experiments in
graphical form. Polyamide 1 is substantially more inhibitory
when added to the DNA prior to DN331 than when added either
simultaneously with DN331 or after formation of the
DN331zDNA complex. These results likely reflect the similar
affinities of DN331 and polyamide 1 for their respective target
sites in the HIV-1 enhancer (see “Discussion”).
Full-length Ets-1 Binds DNA Cooperatively with the p50
Subunit of NF-kB—The previous binding experiments were
done with the high affinity deletion peptide DN331, which
consists of the Ets-1 DNA-binding domain. Full-length Ets-1
binds to the HIV-1 probe with extremely low affinity, due to the
presence of autoinhibitory regions in the protein (25). Ets-1 has
been shown to form partnerships with a number of different
proteins, which appears to counteract these negative auto-
inhibitory effects (reviewed in Refs. 18 and 19). A recent report
showed that Ets-1 physically interacts with NF-kB/NFAT pro-
teins (13), and other studies have shown that the HIV-1 NF-kB
sites are bound by heterodimers of p50/p65 and p50/RelB, and
by p50 homodimers (reviewed in Ref. 7). This prompted us to
analyze whether Ets-1 can bind cooperatively with the p50
subunit of NF-kB and form a ternary protein-protein-DNA
complex. To this end we constructed a synthetic double-
stranded oligonucleotide that contained the binding sites for
Ets-1 and polyamides 1 and 3 in the natural sequence context
and, in addition, a binding site for p50 in close proximity to the
Ets-1-binding site (Fig. 4A). In a gel mobility shift assay, this
probe was bound by full-length Ets-1 with very low affinity; at
FIG. 2. Inhibition of Ets-1 DNA binding by polyamide 1. A,
polyamide 1 titration on the DN331zDNA complex. Autoradiogram of a
representative gel mobility shift assay showing the inhibitory effect of
polyamide 1 on DN331 binding is shown. Positions of the free probe (F)
and bound probe (B) are indicated. The concentration of DN331 was
constant (12 nM in lanes 2–10), and the concentration of the 43-bp probe
(position 2160 to 2117) was 50 pM. The polyamide concentrations were
1.56, 3.125, 6.25, 12.5, 25, 50, 100, and 200 nM in lanes 3–10, respec-
tively. The polyamide was preincubated with the DNA probe for 20 min
at room temperature before addition of the protein, followed by 20–30
min incubation on ice. B, graphical representation of the decrease of the
fraction of bound probe as a function of the polyamide concentration.
Closed squares represent the data points obtained for polyamide 1; open
squares represent data for polyamide 3. C, DNase I footprint titration
experiment with polyamides 1 and 3 in the absence (2) or presence (1)
of 9.6 nM DN331 protein. Polyamides were incubated with the radiola-
beled probe prior to addition of DN331. The polyamide concentrations
were 0 nM (lanes 2, 6, 10, and 14), 4 nM (lanes 3, 7, 11, and 15), 20 nM
(lanes 4, 8, 12, and 16), and 100 nM (lanes 5, 9, 13, and 17). Lanes 1 and
18 show a G 1 A sequencing ladder. The regions protected by poly-
amides and by DN331 are indicated alongside the sequencing ladder.
Note the two DNase I-hypersensitive sites are characteristic of the
DN331 footprint.
FIG. 3. Order of polyamide 1 addition determines the inhibi-
tory activity of the polyamide on DN331 DNA binding. Gel mo-
bility shift assays were carried out as described in the legend to Fig. 2,
where the indicated concentrations of polyamide 1 were added to the
DNA 20 min prior to adding DN331 (closed squares), or added simulta-
neously with DN331 (closed triangles), or DN331 was incubated with
the DNA for 30 min prior to the addition of polyamide (open squares).
After a subsequent 20-min incubation, the reaction mixtures were sub-
jected to nondenaturing gel electrophoresis. The dried gel was subjected
to phosphorimage analysis, and the fraction of DNA in the Ets-1zDNA
complex in the presence of polyamide was plotted as a function of
polyamide concentration, normalized to the amount of DNA in complex
in the absence of polyamide (a value of 1.0).
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the highest protein concentration used (272 nM), only 6% of the
probe was bound (Fig. 4B, lanes 10–15). To examine whether
p50 and Ets-1 bind the HIV-1 enhancer in a cooperative fash-
ion, increasing concentrations of Ets-1 were added to a con-
stant but limiting amount of p50 (6 nM). Coincubation of p50
and Ets-1 yielded a complex that migrated at a slower mobility
than that formed with either p50 or Ets-1 alone (Fig. 4B, lanes
3–8). Significantly, ternary complex formation was detectable
at the lowest concentration of Ets-1 used, which did not yield a
complex with Ets-1 alone (compare lanes 3 and 10 in Fig. 4B).
Furthermore, at the maximal concentration of Ets-1 used in the
presence of p50, approximately 90% of the probe was shifted
into the ternary complex (lane 8), whereas less than 10% of the
probe was shifted when Ets-1 was used in the absence of p50 at
the same concentration (lane 15), and only 50% of the probe
was shifted when p50 was used alone (lane 2). When this same
experiment was repeated at a lower concentration of p50 (3 nM),
only 13% of the probe was converted into the p50zDNA complex
in the absence of Ets-1 (Fig. 5, lane 3). The addition of full-
length Ets-1 had an even more dramatic effect on DNA binding
under these conditions (Fig. 5, lane 4). These data indicate that
DNA binding by Ets-1 and p50 is highly cooperative.
Inhibition of Ternary Complex Formation by Polyamide
1—We next examined whether the cooperative DNA binding
activity by combined p50 and Ets-1 proteins would still be
susceptible to polyamide inhibition. When the DNA probe was
preincubated with polyamides prior to incubation with pro-
teins, the DNA binding activity of p50 was not inhibited by
either polyamide 1 or the mismatch polyamide 2 (Fig. 6, lanes
3–6). The small degree of DNA binding by full-length Ets-1 was
inhibited by polyamide 1 but not by polyamide 2 (Fig. 6, lanes
13–16). When p50 and Ets-1 were added to the DNA probe after
preincubation with polyamide 1, ternary complex formation
was prevented, whereas p50 was still able to bind the probe
(Fig. 6, lanes 8 and 9). The mismatch polyamide 2 failed to
inhibit ternary complex formation (lanes 10 and 11). These
results confirm that Ets-1 is an integral part of the ternary
complex, and ternary complex formation can be prevented by
blocking Ets-1 access to its recognition site.
A titration experiment showed that the polyamide concen-
tration required for 50% inhibition of the ternary complex was
approximately 3–6 nM. Complete inhibition was achieved with
a polyamide concentration of 100–200 nM (data not shown).
This concentration range is similar to the concentration of
polyamide 1 required for preventing the high affinity deletion
peptide DN331 from binding to its recognition site (see Fig. 2B).
We also tested whether ternary complex formation could be
prevented by blocking p50 binding with polyamide 3. Polyam-
ide 3 binds immediately upstream of the p50-binding site in the
38-mer DNA probe (Fig. 4A), and preincubation of the probe
with polyamide 3 blocks binding of p50 and, hence, ternary
complex formation (Fig. 7). However, a much higher concentra-
tion of polyamide 3 than polyamide 1 is required to block
ternary complex formation. As before, Ets-1 binding is not
affected by polyamide 3, and curiously, the DNA binding affin-
ity of full-length Ets-1 appears to be modestly enhanced (ap-
proximately 2–3-fold) in the presence of polyamide 3. We do not
have an explanation for this small level of enhanced binding.
Cooperative Binding and Polyamide Inhibition of Ets-1 and
NF-kB to the Native HIV-1 Enhancer Sequence—Since the
DNA probe used in the previous gel mobility shift experiments
was an artificial construct, we next tested whether full-length
FIG. 4. Full-length Ets-1 and NF-kB p50 bind DNA coopera-
tively and form a ternary complex. Gel mobility shift experiment
with a 38-bp double-stranded oligonucleotide derived from the HIV-1
enhancer and containing the recognition sites for polyamide 1, Ets-1,
and NF-kB. The p50-binding site was moved close to the Ets-1-binding
site to facilitate interaction in vitro. A, sequence of the top strand of the
synthetic 38-bp probe with Ets-1, NF-kB, and polyamide-binding sites
are indicated. B, gel mobility shift assay with a constant amount of p50
(6 nM, 5.8 ng/20 ml) and increasing concentrations of full-length Ets-1,
compared with full-length Ets-1 in the absence of p50. A plus or minus
sign at the top of the lanes indicates the presence or absence of protein.
The Ets-1 concentrations were 8.5, 17, 34, 68, 136, and 272 nM in lanes
3–8 and 10–15, respectively. The positions of the protein-DNA com-
plexes and the free probe (F) are indicated.
FIG. 5. Cooperative interaction of Ets-1 and p50 at low concen-
trations of p50. A gel mobility shift assay with the 38-bp oligonucleo-
tide probe was carried out as described in the legend to Fig. 4, at a p50
concentration of 3 nM and at an Ets-1 concentration of 136 nM, where
indicated. The positions of protein-DNA complexes and free probe (F)
are indicated.
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Ets-1 and the p50 subunit of NF-kB could bind cooperatively to
the native HIV-1 enhancer sequence and form a ternary com-
plex. A double-stranded 73-bp oligonucleotide, corresponding to
positions 2160 to 292 of the HIV-1 enhancer and containing
the binding sites for polyamides 1 and 3, Ets-1, LEF-1, and
NF-kB, was used as a probe in gel mobility shift experiments.
As before, in the absence of p50, Ets-1 bound to the 73-mer with
very low affinity (Fig. 8A, lanes 2–5). In contrast, coincubation
of a constant concentration of p50 and increasing concentra-
tions of Ets-1 yielded a complex that migrated with a slower
mobility than that formed with p50 alone, and the intensity of
this ternary complex increased with increasing Ets-1 concen-
trations (Fig. 8A, lanes 6–10). These data indicate that full-
length Ets-1 can bind the native HIV-1 enhancer cooperatively
with NF-kB even though the NF-kB and Ets-1 sites are sepa-
rated by 35 bp in the native HIV-1 sequence. Additionally,
polyamide 1 inhibits ternary complex formation by preventing
Ets-1 binding without affecting p50 binding (Fig. 8B, lanes
5–7). Polyamide 3, which binds downstream of the Ets-1 recog-
nition site and 30–36 bp upstream of NF-kB in the native
HIV-1 sequence, does not significantly inhibit ternary complex
formation (Fig. 8B, lanes 8–10). The 2160 to 292 probe con-
tained only one binding site for NF-kB, whereas two sites are
present in the native HIV-1 enhancer sequence (Fig. 1). To
assess whether polyamide 1 could also inhibit ternary complex
formation on the full native enhancer sequence, we used a
143-bp DNA probe corresponding to nucleotide positions 2175
to 233 of the HIV-1 enhancer/promoter sequence. Similar to
the results for the 73-bp probe (Fig. 8B), we find that polyamide
1 can inhibit formation of the Ets-1zNF-kBzDNA complex with
this longer probe containing two NF-kB sites (Fig. 9). As before,
in the absence of p50, full-length Ets-1 binds very weakly to
this DNA probe (lanes 2–4). In the absence of Ets-1, p50 forms
two complexes on this probe (lane 5). The addition of a 100-fold
molar excess of unlabeled 143-bp HIV-1 DNA to the p50-la-
beled DNA complex reveals that the faster migrating species is
nonspecific, whereas the slower migrating species is the spe-
cific p50-DNA complex (lane 6). Interestingly, the nonspecific
complex is not observed in the presence of Ets-1 (lanes 7–9) and
reappears when Ets-1 binding is inhibited by polyamide 1 (lane
12). It seems likely that Ets-1 can recruit p50 from the nonspe-
cific complex into the specific ternary Ets-1zp50zDNA complex.
DISCUSSION
Differential Inhibition of Ets-1 Binding by Two Polyamides
Flanking the Ets-1 Recognition Site in the HIV-1 Enhancer—
Ets-1 is an important regulator of many promoters in lymphoid
cells, including the HIV-1 long terminal repeat. We show here
that Ets-1 can be inhibited from binding to its recognition
sequence in the HIV-1 enhancer by a small Py-Im DNA-binding
ligand. Polyamides bind in the minor groove of DNA and,
significantly, can inhibit minor groove binding proteins by
binding to a recognition site that is adjacent to but does not
coincide with the recognition site of the DNA-binding protein
(6). This is a crucial requirement for achieving specificity in
inhibiting binding of ubiquitous transcription factors to certain
promoters. We speculate that polyamides, which bind B-type
DNA, can inhibit minor groove binding proteins such as TBP
and LEF-1 because polyamide-bound DNA is likely resistant to
the extensive bending and unwinding that accompanies DNA
binding by these transcription factors (12, 27–29). In contrast,
we document here that a Py-Im polyamide can also inhibit the
DNA binding activity of Ets-1, a winged helix-turn-helix pro-
tein that primarily contacts DNA in the major groove with
additional adjacent phosphate contacts.
The Ets-1-binding site in the HIV-1 enhancer is flanked on
both sides by polyamide-binding sites, upstream by polyamide
1 and downstream by polyamide 3. Both polyamide-binding
sites partially overlap with the protein-binding site. However,
only polyamide 1 blocks Ets-1 binding, whereas polyamide 3
has no effect, despite the fact that polyamide 3 binds even
closer to the GGA recognition core than does polyamide 1 (Fig.
1). This differential polyamide inhibition of Ets-1 DNA binding
can be explained within the context of the high resolution
model of ETS domain-DNA interactions. The ETS domain dis-
plays a structural motif known as a winged helix-turn-helix
which includes three a helices and a b sheet (14–16, 30, 31).
Significantly, DNA contacts are confined to one face of the DNA
helix. Helix 3 of the helix-turn-helix motif contacts the 59-
GGA(A/T)-39 core within the major groove. A b sheet “wing”
and a turn separating helices 2 and 3 are tethered to the
phosphate backbone on both sides of the major groove contacts
made by the recognition helix (16) (Fig. 1). Polyamide 3, which
does not disrupt Ets-1 binding, interacts in the minor groove
just beyond the phosphate contacts made by the wing. Polyam-
ide 3 binds the symmetrical DNA sequence 59-AGTACT-39 and
can conceivably bind in either orientation, that is either with
its terminal b-alanine proximal to the Ets-1 site or its “hairpin
turn” g-aminobutyric acid proximal to the Ets-1 site. Depend-
ing on the orientation of the polyamide, the b-alanine amide
will form a hydrogen bond to the O-2 of T23 or the g-aminobu-
tyric acid amide will form a hydrogen bond to the N-3 of A239
(32) (see Fig. 1). Although ets proteins make a phosphate con-
tact at T23, neither of these potential polyamide contacts is
sufficient to block Ets-1 from binding. On the other hand, an
Im/Py pair and a Py/Im pair of polyamide 1 interact with G69/C6
and C59/G5, thus interfering with the phosphate contacts made
by the ETS domain to nucleotides G69 and C59 (Fig. 1). Since the
polyamides do not make phosphate contacts with DNA, it is
likely that inhibition arises from a steric blockage of the minor
groove by the polyamide. These results indicate that targeting
FIG. 6. Specific inhibition of ternary complex formation by
polyamide 1. A gel mobility shift assay with the 38-bp oligonucleotide
probe was carried out as in Fig. 4. Lane 1 contained no added protein;
lanes 2–6 contained p50; lanes 7–11 contained both p50 and Ets-1; and
lanes 12-16 contained Ets-1. The protein concentrations were 136 nM
full-length Ets-1 and 6 nM p50. Polyamide 1 was preincubated with the
probe for 20 min at ambient temperature at a concentration of 100 nM
(lanes 3, 8, and 13) and 200 nM (lanes 4, 9 and 14); mismatch polyamide
2 was added at 100 and 200 nM in lanes 5, 10, 15 and 6, 11, 16,
respectively. The positions of protein-DNA complexes and the free
probe (F) are indicated.
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sites adjacent to protein-binding sites may not be sufficient for
polyamide inhibition of certain DNA-binding proteins. This
approach was successful with TBP and LEF-1, likely because
these factors extensively bend and unwind the DNA upon bind-
ing, whereas polyamides bound to DNA likely prevent this type
of distortion. For Ets-1, however, interference with phosphate
contacts was necessary to inhibit binding. These results dem-
onstrate the importance of taking the three-dimensional struc-
ture of the protein-DNA complex into consideration when de-
signing polyamides to disrupt a transcription factor-DNA
interaction.
We find that the order of addition of polyamide 1 and Ets-1
(DN331) has a dramatic effect on the inhibitory action of the
polyamide (Fig. 3). More pronounced inhibition is observed if
the polyamide is allowed access to its DNA target prior to the
addition of DN331 protein than if the protein-DNA complex is
allowed to form prior to the addition of polyamide. An interme-
diate result is obtained if both polyamide and DN331 are added
to the DNA simultaneously. This dependence on order of addi-
tion likely reflects the similar affinities of the two DNA ligands
for their recognition sites: DN331 binds a selected high affinity
site with an equilibrium dissociation constant of 8.5 pM (25) and
FIG. 7. Inhibition of ternary com-
plex formation with polyamides 1
and 3 on the 38-bp probe. Gel mobility
shift assays were performed as in Fig. 6
with increasing concentrations of poly-
amides (Polyam.). Lanes 3–10 contained
polyamide 1, and lanes 13–20 contained
polyamide 3 at the following final concen-
trations: 1.6, 3.1, 6.3, 12.5, 25, 50, 100,
200 nM, respectively. The positions of pro-
tein-DNA complexes and the free probe
(F) are indicated.
FIG. 8. Full-length Ets-1 and NF-kB p50 form a ternary complex with the native HIV-1 enhancer sequence that is inhibited by
polyamide 1. A, sequence of the top strand of the 73-bp DNA probe (positions 2160 to 292). B, gel mobility shift experiment with increasing
concentrations of full-length Ets-1 in the absence of p50 (lanes 2–5) or in the presence of p50 (lanes 7–10). p50 was used at a constant concentration
of 6 nM. The concentrations of Ets-1 were 17, 34, 68, and 136 nM in lanes 2–5 and 7–10, respectively. C, inhibition of ternary complex formation
between Ets-1, p50, and the native HIV-1 enhancer sequence. The proteins were added at constant concentrations of 136 nM for Ets-1 and 11 nM
for p50. The polyamide (Polyam.) concentrations were 1 nM (lanes 5 and 8), 10 nM (lanes 6 and 9), and 100 nM (lanes 7 and 10). Free probe (F) and
protein-DNA complexes are indicated.
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binds the HIV-1 site with approximately 10-fold lower affinity.
Similarly, polyamide 1 binds its target site with a Kd of 50 pM.
Given these comparable binding affinities, which ever ligand
has initial access to its target site will be the primary bound
species. In the context of the living cell, it is likely that tran-
scription factors are displaced from promoter sequences during
both DNA replication and during mitotic chromosome conden-
sation (33, 34); thus, polyamides would have access to their
target sites during these two phases of the cell cycle providing
a window of opportunity for binding.
Ternary Complex Formation of Full-length Ets-1 and NF-kB
p50 on Adjacent Binding Sites—Full-length Ets-1 binds to the
HIV-1 enhancer with very low affinity. This result is in agree-
ment with published reports showing that the DNA binding
activity of many members of the ets family is negatively regu-
lated by autoinhibitory regions present in the protein. It has
been suggested that cooperation with other factors counteracts
the autoinhibitory effect of Ets-1 (reviewed in Refs. 18 and 19).
Indeed, we also show that when full-length Ets-1 is coincubated
with the p50 subunit of NF-kB and a DNA probe containing
binding sites for both proteins, Ets-1 binds cooperatively with
p50 and forms a ternary complex that migrates with slower
mobility than either protein-DNA complex alone.
The cooperativity observed between Ets-1 and p50 is most
likely the result of direct physical interaction between the two
proteins that are brought to close vicinity by binding to adja-
cent sites on the same DNA fragment. A recent report showed
that Ets-1 physically interacts with NF-kB/NFAT proteins in
vitro and in vivo and that this interaction requires the presence
of DNA for both binding sites (13). We also found that cooper-
ative binding between Ets-1 and p50 required a DNA probe
containing a binding site for both proteins on the same frag-
ment. We could not detect cooperative binding with oligomers
that contained either the Ets-1 or p50 recognition site alone nor
with an equimolar mixture of both oligomers (data not shown).
Significantly, ternary complex formation is inhibited by pol-
yamide 1, which prevents Ets-1 from binding to its recognition
site. It is noteworthy that inhibition of Ets-1 DNA binding in
the ternary complex is achieved with the same concentrations
of polyamide 1 as required for inhibition of DNA binding by the
high affinity deletion peptide DN331. This observation suggests
that full-length Ets-1 in the ternary complex binds to its DNA
recognition site with a similar affinity as the isolated high
affinity deletion peptide DN331.
The artificial probe that was used in these experiments con-
tained a polyamide 3-binding site upstream of the p50-binding
site (Fig. 4A). Polyamide 3 prevented ternary complex forma-
tion as well, by preventing p50 from binding to its recognition
sequence. However, the concentration of polyamide 3 required
for inhibition of p50 was significantly higher than that required
for polyamide 1 inhibition of Ets-1. It is likely that a higher
concentration of polyamide 3 is required because of the differ-
ent modes of DNA recognition and binding utilized by these two
proteins (15, 35, 36). Ets-1 binds DNA as a monomer, whereas
p50 binds as a dimer; furthermore, the polyamide 3-binding
site may be too distant from the minor groove contacts made by
p50, which are located toward the center of the 10-base pair
recognition site. The p50 dimer contacts DNA predominantly in
the major groove, where the dimer grips the DNA duplex like a
set of jaws, whereas minor groove contacts are limited to only
two amino acid residues (36). It is therefore likely that the
location of the polyamide 3-binding site is not optimal for
inhibition of the minor groove contacts made by p50.
Cooperative Binding of Ets-1 and NF-kB p50 on Non-adja-
cent Sites in the HIV-1 Enhancer—We show that Ets-1 binds
cooperatively with NF-kB p50 not only on adjacent binding
sites but also on the natural HIV-1 enhancer sequence. In the
HIV-1 enhancer sequence the binding sites for Ets-1 and
NF-kB are separated by approximately 35 base pairs, with an
intervening LEF-1-binding site. LEF-1 is considered an archi-
tectural protein that coordinates interactions between multiple
proteins. For example, LEF-1 induces a sharp bend in the TCR
a-gene enhancer, which facilitates interactions between Ets-1,
CBFa2, and ATF/CREB transcription factors bound at distant
sites flanking the LEF-1-binding site (11). However, we found
that cooperativity between Ets-1 and p50 on the HIV-1 en-
hancer did not require the presence of LEF-1. Since both the
ETS domain and the p50 dimer induce a moderate bend in the
DNA upon binding (15, 36), it is conceivable that the combined
effect of the two proteins on the DNA configuration is sufficient
to bring their binding sites in close proximity to allow protein-
protein interaction.
Numerous physical interactions between ets family members
and other transcription factors, including p50, have been de-
scribed (reviewed in Ref. 19). However, very few studies have
shown cooperative DNA binding and ternary protein-protein-
DNA complex formation between Ets proteins and other tran-
scription factors (11). Although direct physical association be-
tween Ets-1 and p50 has been demonstrated (13), this is the
first report providing evidence for cooperative DNA binding
and ternary complex formation by Ets-1 and p50 on the HIV-1
enhancer sequence.
Cooperative interactions between transcription factors ap-
pear to be important for regulation of gene expression in gen-
eral, and it is thought that these interactions may represent
targets for novel antiviral therapies. The in vitro experiments
described in this report, together with in vivo assays described
elsewhere (6), suggest that small Py-Im polyamides may rep-
resent the basis for developing novel therapeutic agents that
target transcription.
FIG. 9. Ternary complex formation and polyamide 1 inhibition
of Ets-1 and p50 on the native HIV-1 enhancer sequence. Gel
mobility shift experiment with the 144-bp probe, corresponding to nu-
cleotide positions 2175 to 233 of the HIV-1 LTR, and increasing con-
centrations of full-length Ets-1 in the absence of p50 (lanes 2–4) or in
the presence of p50 (lanes 7–9). p50 was used at a constant concentra-
tion of 6 nM, where indicated (1). The concentrations of Ets-1 were 68,
136, 272 nM in lanes 2–4 and 7–9, respectively. The concentration of
Ets-1 in lanes 10–12 was 272 nM. The polyamide (Polyam.) concentra-
tions were 50, 100, 200 nM in lanes 10–12, respectively. In lane 6, a
100-fold molar excess of the unlabeled probe was added as a specific
competitor (Comp.). Free probe (F) and protein-DNA complexes are
indicated. The complex with one p50 site occupied is denoted (p50)1 and
the complex with two occupied sites is denoted (p50)2. The nonspecific
p50-DNA complex observed in the absence of Ets-1 is indicated by an
asterisk.
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